Verfahren zur Herstellung von neuen Phenylisopropylaminen

Compounds of general formula (I) and salts thereof where R1 = lower alkyl R2 = H or propyl, propenyl, or propynyl, which can further be substd. by halogen or OH R3 = H, halogen, nitro, amino, or diazonium R4 = F, Br, I, nitro, diazonium, or amino, and H where R3 is not H. The p-substd. compounds are...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TOROK,SANDOR, SOMFAI,EVA, KOSA,ILDIKO, SANDOR,ILDIKO, ECSERY,ZOLTAN, KNOLL,JOZSEF
Format:	Patent
Sprache:	ger
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	TOROK,SANDOR SOMFAI,EVA KOSA,ILDIKO SANDOR,ILDIKO ECSERY,ZOLTAN KNOLL,JOZSEF
description	Compounds of general formula (I) and salts thereof where R1 = lower alkyl R2 = H or propyl, propenyl, or propynyl, which can further be substd. by halogen or OH R3 = H, halogen, nitro, amino, or diazonium R4 = F, Br, I, nitro, diazonium, or amino, and H where R3 is not H. The p-substd. compounds are hallucinogens (10-20 times more active than mescaline), depressants or analgesics (equivalent to tetrabenazine). They are free of the latter's side effects, e.g. they are non-addicting. The o-substd. compounds are potent and long-acting coronary dilators.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CH529717A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CH529717A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CH529717A3</originalsourceid><addsrcrecordid>eNrjZLAMSy1KS8woSs1TqCotUvBILSouSc3JKc1LVyjLz1PISy0FygRkpOZV5mQW5xcU5RdU5iTmZual5vEwsKYl5hSn8kJpbgY5N9cQZw_d1IL8-NTigsTk1LzUknhnD1MjS3NDc0djggoAjzQuYg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Verfahren zur Herstellung von neuen Phenylisopropylaminen</title><source>esp@cenet</source><creator>TOROK,SANDOR ; SOMFAI,EVA ; KOSA,ILDIKO ; SANDOR,ILDIKO ; ECSERY,ZOLTAN ; KNOLL,JOZSEF</creator><creatorcontrib>TOROK,SANDOR ; SOMFAI,EVA ; KOSA,ILDIKO ; SANDOR,ILDIKO ; ECSERY,ZOLTAN ; KNOLL,JOZSEF</creatorcontrib><description>Compounds of general formula (I) and salts thereof where R1 = lower alkyl R2 = H or propyl, propenyl, or propynyl, which can further be substd. by halogen or OH R3 = H, halogen, nitro, amino, or diazonium R4 = F, Br, I, nitro, diazonium, or amino, and H where R3 is not H. The p-substd. compounds are hallucinogens (10-20 times more active than mescaline), depressants or analgesics (equivalent to tetrabenazine). They are free of the latter's side effects, e.g. they are non-addicting. The o-substd. compounds are potent and long-acting coronary dilators.</description><edition>1</edition><language>ger</language><creationdate>1972</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19721031&DB=EPODOC&CC=CH&NR=529717A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19721031&DB=EPODOC&CC=CH&NR=529717A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TOROK,SANDOR</creatorcontrib><creatorcontrib>SOMFAI,EVA</creatorcontrib><creatorcontrib>KOSA,ILDIKO</creatorcontrib><creatorcontrib>SANDOR,ILDIKO</creatorcontrib><creatorcontrib>ECSERY,ZOLTAN</creatorcontrib><creatorcontrib>KNOLL,JOZSEF</creatorcontrib><title>Verfahren zur Herstellung von neuen Phenylisopropylaminen</title><description>Compounds of general formula (I) and salts thereof where R1 = lower alkyl R2 = H or propyl, propenyl, or propynyl, which can further be substd. by halogen or OH R3 = H, halogen, nitro, amino, or diazonium R4 = F, Br, I, nitro, diazonium, or amino, and H where R3 is not H. The p-substd. compounds are hallucinogens (10-20 times more active than mescaline), depressants or analgesics (equivalent to tetrabenazine). They are free of the latter's side effects, e.g. they are non-addicting. The o-substd. compounds are potent and long-acting coronary dilators.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1972</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAMSy1KS8woSs1TqCotUvBILSouSc3JKc1LVyjLz1PISy0FygRkpOZV5mQW5xcU5RdU5iTmZual5vEwsKYl5hSn8kJpbgY5N9cQZw_d1IL8-NTigsTk1LzUknhnD1MjS3NDc0djggoAjzQuYg</recordid><startdate>19721031</startdate><enddate>19721031</enddate><creator>TOROK,SANDOR</creator><creator>SOMFAI,EVA</creator><creator>KOSA,ILDIKO</creator><creator>SANDOR,ILDIKO</creator><creator>ECSERY,ZOLTAN</creator><creator>KNOLL,JOZSEF</creator><scope>EVB</scope></search><sort><creationdate>19721031</creationdate><title>Verfahren zur Herstellung von neuen Phenylisopropylaminen</title><author>TOROK,SANDOR ; SOMFAI,EVA ; KOSA,ILDIKO ; SANDOR,ILDIKO ; ECSERY,ZOLTAN ; KNOLL,JOZSEF</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CH529717A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1972</creationdate><toplevel>online_resources</toplevel><creatorcontrib>TOROK,SANDOR</creatorcontrib><creatorcontrib>SOMFAI,EVA</creatorcontrib><creatorcontrib>KOSA,ILDIKO</creatorcontrib><creatorcontrib>SANDOR,ILDIKO</creatorcontrib><creatorcontrib>ECSERY,ZOLTAN</creatorcontrib><creatorcontrib>KNOLL,JOZSEF</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TOROK,SANDOR</au><au>SOMFAI,EVA</au><au>KOSA,ILDIKO</au><au>SANDOR,ILDIKO</au><au>ECSERY,ZOLTAN</au><au>KNOLL,JOZSEF</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Verfahren zur Herstellung von neuen Phenylisopropylaminen</title><date>1972-10-31</date><risdate>1972</risdate><abstract>Compounds of general formula (I) and salts thereof where R1 = lower alkyl R2 = H or propyl, propenyl, or propynyl, which can further be substd. by halogen or OH R3 = H, halogen, nitro, amino, or diazonium R4 = F, Br, I, nitro, diazonium, or amino, and H where R3 is not H. The p-substd. compounds are hallucinogens (10-20 times more active than mescaline), depressants or analgesics (equivalent to tetrabenazine). They are free of the latter's side effects, e.g. they are non-addicting. The o-substd. compounds are potent and long-acting coronary dilators.</abstract><edition>1</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	ger
recordid	cdi_epo_espacenet_CH529717A
source	esp@cenet
title	Verfahren zur Herstellung von neuen Phenylisopropylaminen
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T21%3A44%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TOROK,SANDOR&rft.date=1972-10-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECH529717A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true